NO20001149L - Benzoksazin- og benzotiazinderivater og deres anvendelse i farmasøytiske midler - Google Patents
Benzoksazin- og benzotiazinderivater og deres anvendelse i farmasøytiske midlerInfo
- Publication number
- NO20001149L NO20001149L NO20001149A NO20001149A NO20001149L NO 20001149 L NO20001149 L NO 20001149L NO 20001149 A NO20001149 A NO 20001149A NO 20001149 A NO20001149 A NO 20001149A NO 20001149 L NO20001149 L NO 20001149L
- Authority
- NO
- Norway
- Prior art keywords
- benzoxazine
- pharmaceuticals
- benzothiazine derivatives
- benzothiazine
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19740386 | 1997-09-08 | ||
| DE19826232 | 1998-06-05 | ||
| PCT/DE1998/002690 WO1999012915A1 (de) | 1997-09-08 | 1998-09-08 | Benzoxazin- und benzothiazin-derivate und deren verwendung in arzneimitteln |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20001149D0 NO20001149D0 (no) | 2000-03-07 |
| NO20001149L true NO20001149L (no) | 2000-05-05 |
| NO317416B1 NO317416B1 (no) | 2004-10-25 |
Family
ID=26039966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20001149A NO317416B1 (no) | 1997-09-08 | 2000-03-07 | Benzoksazin- og benzotiazinderivater og deres anvendelse i farmasoytiske midler |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6365736B1 (no) |
| EP (1) | EP1015437B1 (no) |
| JP (1) | JP2001515892A (no) |
| KR (1) | KR20010023746A (no) |
| CN (1) | CN1136203C (no) |
| AT (1) | ATE255567T1 (no) |
| AU (1) | AU741297B2 (no) |
| BR (1) | BR9812160A (no) |
| CA (1) | CA2303440A1 (no) |
| DE (1) | DE59810359D1 (no) |
| DK (1) | DK1015437T3 (no) |
| ES (1) | ES2212361T3 (no) |
| HU (1) | HUP0003455A3 (no) |
| IL (1) | IL134930A (no) |
| IS (1) | IS5390A (no) |
| NO (1) | NO317416B1 (no) |
| NZ (1) | NZ503230A (no) |
| PL (1) | PL339073A1 (no) |
| PT (1) | PT1015437E (no) |
| SK (1) | SK3102000A3 (no) |
| TR (1) | TR200000637T2 (no) |
| TW (1) | TW457236B (no) |
| WO (1) | WO1999012915A1 (no) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19844291A1 (de) | 1998-09-18 | 2000-03-23 | Schering Ag | Benzoxazin- und Benzothiazin-Derivate und deren Verwendung in Arzneimitteln |
| WO2000024746A1 (de) * | 1998-10-27 | 2000-05-04 | Schering Aktiengesellschaft | Thienooxazine als nos-hemmer |
| DE19941115A1 (de) * | 1999-08-25 | 2001-03-01 | Schering Ag | Neue Benzoxazin- und Bezothiazin-Derivate und deren Verwendung in Arzneimitteln |
| DE10020667A1 (de) | 2000-04-19 | 2001-11-22 | Schering Ag | Neue Benzoxazin- und Benzothiazin-Derivate und deren Verwendung in Arzneimitteln |
| WO2001081324A1 (de) * | 2000-04-25 | 2001-11-01 | Schering Aktiengesellschaft | Benzoxazin- und benzothiazin-derivate mit nos-inhibitorischen und antioxidativen eigenschaften |
| ITTO20040125A1 (it) * | 2004-03-01 | 2004-06-01 | Rotta Research Lab | Nuove amidine eterocicliche inibitrici la produzione di ossido d'azoto (no) ad attivita' antinfiammatoria ed analgesica |
| TW200732331A (en) * | 2005-12-28 | 2007-09-01 | Takeda Pharmaceuticals Co | Fused heterocyclic compound and use thereof |
| KR101044880B1 (ko) * | 2008-06-12 | 2011-06-28 | 일양약품주식회사 | 항궤양제 화합물의 합성에 유용한 중간체의 제조방법 |
| KR101293384B1 (ko) * | 2010-10-13 | 2013-08-05 | 주식회사 대웅제약 | 신규 피리딜 벤조옥사진 유도체, 이를 포함하는 약학 조성물 및 이의 용도 |
| CN106279139B (zh) * | 2016-08-08 | 2018-12-28 | 湘潭大学 | 可用作sglt2抑制剂的化合物及其制备方法和用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5629322A (en) * | 1994-11-15 | 1997-05-13 | Merck & Co., Inc. | Cyclic amidine analogs as inhibitors of nitric oxide synthase |
-
1998
- 1998-09-08 CA CA002303440A patent/CA2303440A1/en not_active Abandoned
- 1998-09-08 ES ES98952562T patent/ES2212361T3/es not_active Expired - Lifetime
- 1998-09-08 US US09/581,119 patent/US6365736B1/en not_active Expired - Fee Related
- 1998-09-08 PL PL98339073A patent/PL339073A1/xx not_active Application Discontinuation
- 1998-09-08 WO PCT/DE1998/002690 patent/WO1999012915A1/de not_active Application Discontinuation
- 1998-09-08 JP JP2000510723A patent/JP2001515892A/ja active Pending
- 1998-09-08 HU HU0003455A patent/HUP0003455A3/hu unknown
- 1998-09-08 AU AU10220/99A patent/AU741297B2/en not_active Ceased
- 1998-09-08 DE DE59810359T patent/DE59810359D1/de not_active Expired - Fee Related
- 1998-09-08 KR KR1020007002401A patent/KR20010023746A/ko active IP Right Grant
- 1998-09-08 DK DK98952562T patent/DK1015437T3/da active
- 1998-09-08 IL IL13493098A patent/IL134930A/en not_active IP Right Cessation
- 1998-09-08 AT AT98952562T patent/ATE255567T1/de not_active IP Right Cessation
- 1998-09-08 BR BR9812160-0A patent/BR9812160A/pt not_active Application Discontinuation
- 1998-09-08 EP EP98952562A patent/EP1015437B1/de not_active Expired - Lifetime
- 1998-09-08 CN CNB988109255A patent/CN1136203C/zh not_active Expired - Fee Related
- 1998-09-08 PT PT98952562T patent/PT1015437E/pt unknown
- 1998-09-08 NZ NZ503230A patent/NZ503230A/en unknown
- 1998-09-08 TR TR2000/00637T patent/TR200000637T2/xx unknown
- 1998-09-08 SK SK310-2000A patent/SK3102000A3/sk unknown
- 1998-09-08 TW TW087114926A patent/TW457236B/zh not_active IP Right Cessation
-
2000
- 2000-02-29 IS IS5390A patent/IS5390A/is unknown
- 2000-03-07 NO NO20001149A patent/NO317416B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IS5390A (is) | 2000-02-29 |
| AU1022099A (en) | 1999-03-29 |
| WO1999012915A1 (de) | 1999-03-18 |
| HUP0003455A2 (hu) | 2002-11-28 |
| EP1015437B1 (de) | 2003-12-03 |
| PT1015437E (pt) | 2004-04-30 |
| ES2212361T3 (es) | 2004-07-16 |
| AU741297B2 (en) | 2001-11-29 |
| CN1278802A (zh) | 2001-01-03 |
| CN1136203C (zh) | 2004-01-28 |
| HUP0003455A3 (en) | 2002-12-28 |
| NZ503230A (en) | 2002-03-28 |
| NO317416B1 (no) | 2004-10-25 |
| JP2001515892A (ja) | 2001-09-25 |
| CA2303440A1 (en) | 1999-03-18 |
| NO20001149D0 (no) | 2000-03-07 |
| TW457236B (en) | 2001-10-01 |
| IL134930A (en) | 2004-06-20 |
| US6365736B1 (en) | 2002-04-02 |
| BR9812160A (pt) | 2000-07-18 |
| DE59810359D1 (de) | 2004-01-15 |
| ATE255567T1 (de) | 2003-12-15 |
| IL134930A0 (en) | 2001-07-24 |
| EP1015437A1 (de) | 2000-07-05 |
| KR20010023746A (ko) | 2001-03-26 |
| PL339073A1 (en) | 2000-12-04 |
| SK3102000A3 (en) | 2000-10-09 |
| TR200000637T2 (tr) | 2000-07-21 |
| DK1015437T3 (da) | 2004-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0108396A (pt) | Derivados de pirimidina-4-0na como inibidores de ldl-pla(2) | |
| TR200002480T2 (tr) | İzaşemi tedavisi için guanidin türevleri | |
| PT1214936E (pt) | Utilizacao de derivados de tiazolidina ou pirrolidina de aminoacidos como agentes anti-hiperglicemicos | |
| TR200002355T2 (tr) | 2-(Pürin-9-il)tetrahidrofüran-3,4-diol türevleri | |
| BR0010220A (pt) | Compostos de pirimidinona | |
| NO963506D0 (no) | 4-Heterocyklyl-substituerte kinazolin-derivater, fremgangsmåte for fremstilling derav og deres anvendelse som anti-kreftmidler | |
| UY26082A1 (es) | Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica | |
| AU5624699A (en) | Use of 5ht-6 antagonists | |
| NO990667D0 (no) | Depeptid-benzamidin som kinogenase-inhibitor | |
| NO984290L (no) | Farmas°ytisk nyttige forbindelser | |
| BR0007589A (pt) | Inibidores da proliferação de células | |
| PT998460E (pt) | Novos derivados de tetrazole | |
| SE9802208D0 (sv) | Novel compounds | |
| BR0315662A (pt) | Derivados de 1-(4-benzil-piperazin-1-il)-3-fenil-propenona | |
| DK1015437T3 (da) | Benzoxazin- og benzothiazin-derivater og deres anvendelse i lægemidler | |
| BR0213994A (pt) | Derivados heterocìclicos de glicinamida e seus usos médicos | |
| TR200001909T2 (tr) | Matris metaloprotez inhibitörleri. | |
| NO20001934L (no) | 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse | |
| ATE320422T1 (de) | Metalloproteinase inhibitoren | |
| ATE286395T1 (de) | Antithrombotische mittel | |
| NO980929D0 (no) | Nye benzoksazindionderivater, fremgangsmåte for deres fremstilling og deres anvendelse | |
| DK1104419T3 (da) | N-substituerede azabicyloheptan-derivater, deres fremstilling og anvendelse | |
| DE60014915D1 (de) | Hypoxanthin- und thiohypxanthin-verbindungen | |
| AU2001252772A1 (en) | Use of amines | |
| DK0937075T3 (da) | Hidtil ukendte imidazo- og oxazolopyridiner som phosphodiesteraseinhibitorer |